Elutia Inc.
ELUT
$2.71
-$0.20-6.87%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/4/2025
-
Globe Newswire
4/3/2025
-
GuruFocus
4/3/2025
-
Globe Newswire
4/2/2025
-
Globe Newswire
3/31/2025
-
MarketBeat
3/31/2025
-
MarketBeat
3/27/2025
-
The Fly
3/27/2025
-
Globe Newswire
3/25/2025
-
GuruFocus
3/25/2025
-
The Fly
3/25/2025
-
Globe Newswire
3/18/2025
-
The Fly
3/17/2025
-
MarketBeat
3/14/2025
-
MarketBeat
3/14/2025
-
Ticker Report
3/8/2025
-
MarketBeat
3/7/2025
-
MarketBeat
3/7/2025
-
Ticker Report
3/7/2025
-
GuruFocus
3/7/2025
-
GuruFocus
3/6/2025
-
SeekingAlpha
3/6/2025
-
SeekingAlpha
3/6/2025
-
Seeking Alpha: Transcripts
3/6/2025
-
GuruFocus
3/6/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
240 247 1170
Address
12510 Prosperity Drive
Silver Spring, MD 20904
Silver Spring, MD 20904
Country
Year Founded
Business Description
Sector
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three...
more
